1. by Salim Yusuf, and Sonia Anand
Cost of Prevention
by Salim Yusuf, and Sonia Anand
Circulation
Volume 93(10):
May 15, 1996
Copyright © American Heart Association, Inc. All rights reserved.

2. A, Cholesterol lowering in secondary prevention trials.
A, Cholesterol lowering in secondary prevention trials. CV event rates in the control (C) and treatment (T) groups are plotted as a function of the baseline cholesterol levels. Note that there is a reduction in CV events across a broad range of mean cholesterol values. B, The events from different trials are plotted in relation to the cholesterol levels during the randomized period. Note the continuous relation across the entire range of cholesterol values depicted. The CV events included vary slightly between trials: CV death or MI in 4S; CV death or MI in CARE; CV death, MI, stroke, revascularization, or unexpected death in Post-CABG Trial. The total cholesterol level in the Post-CABG Trial is derived using the values for LDL, triglycerides, and HDL.
Salim Yusuf, and Sonia Anand Circulation. 1996;93:
Copyright © American Heart Association, Inc. All rights reserved.